Patents by Inventor Institut National de la Sante et de la Recherche Medicale (INSERM)

Institut National de la Sante et de la Recherche Medicale (INSERM) has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF A JAK2 MUTATION INVOLVED IN VAQUEZ POLYGLOBULIA
    Publication number: 20130189683
    Abstract: The present invention concerns the V617F variant of the protein-tyrosine kinase JAK2, said variant being responsible for Vaquez Polyglobulia. The invention also relates to a first intention diagnostic method for erythrocytosis and thrombocytosis allowing their association with myeloproliferative disorders, or to the detection of the JAK2 V617F variant in myeloproliferative disorders allowing their reclassification in a new nosological group.
    Type: Application
    Filed: February 15, 2013
    Publication date: July 25, 2013
    Applicants: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, IGR&D SA, UNIVERSITE PARIS-SUD, INSTITUT GUSTAVE-ROUSSY, UNIVERSITE DE VERSAILLES - ST QUENTIN EN YVELINES, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Assistance Publique - Hopitaux De Paris, IGR&D SA, Institut National De La Sante Et De La Recherche Medicale (INSERM), Institut Gustave-Roussy, Universite De Versailles - St Quentin En Yvelines, Universite Paris-Sud
  • SERINE PROTEASE DERIVATIVES AND USES IN THE PREVENTION OR THE TREATMENT OF BLOOD COAGULATION DISORDERS
    Publication number: 20130101570
    Abstract: The present invention relates to chimeric derivatives of serine protease zymogen containing the activation peptide of factor X or a fragment thereof for improving the half-life of said derivatives. Preferably, said chimeric derivatives are protein C and factor X derivatives. The invention also relates to said derivatives for the prevention or treatment of blood coagulation disorders.
    Type: Application
    Filed: January 2, 2013
    Publication date: April 25, 2013
    Applicant: Institut National de la Sante et de la Recherche Mediclae (INSERM)
    Inventor: Institut National de la Sante et de la Recherche Medicale (INSERM)